208 related articles for article (PubMed ID: 33589576)
1. Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma.
Zhang B; Li Q; Wu B; Zhang S; Li L; Jin K; Li S; Li K; Wang Z; Lu Y; Xia L; Sun C
Aging (Albany NY); 2021 Feb; 13(4):5638-5649. PubMed ID: 33589576
[TBL] [Abstract][Full Text] [Related]
2. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
3. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.
Xiao S; Wang R; Wu X; Liu W; Ma S
DNA Cell Biol; 2018 Feb; 37(2):117-125. PubMed ID: 29412778
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.
Zang W; Wang T; Wang Y; Chen X; Du Y; Sun Q; Li M; Dong Z; Zhao G
Oncotarget; 2016 Apr; 7(15):19960-74. PubMed ID: 26799587
[TBL] [Abstract][Full Text] [Related]
6. The Long Non-Coding RNA TP73-AS1 Interacted With miR-142 to Modulate Brain Glioma Growth Through HMGB1/RAGE Pathway.
Zhang R; Jin H; Lou F
J Cell Biochem; 2018 Apr; 119(4):3007-3016. PubMed ID: 28379612
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA TP73-AS1 contributes to glioma tumorigenesis by sponging the miR-103a/GALNT7 pathway.
Wang JB; Chen XL; Han ZB; Wang HW; Wang ZH; Li NN; Lin ZG
Brain Res; 2020 Aug; 1741():146886. PubMed ID: 32416102
[TBL] [Abstract][Full Text] [Related]
8. Role of long non-coding RNA TP73-AS1 in cancer.
Chen C; Shu L; Zou W
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652459
[TBL] [Abstract][Full Text] [Related]
9. An immune-related lncRNA signature for patients with anaplastic gliomas.
Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.
Chen Y; Wang Y; He Q; Wang W; Zhang T; Wang Z; Dong J; Lan Q; Zhao J
Cancer Med; 2021 Jul; 10(13):4644-4657. PubMed ID: 34121368
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.
Zhang Q; Liu XJ; Li Y; Ying XW; Chen L
Technol Cancer Res Treat; 2021; 20():15330338211011966. PubMed ID: 34159865
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
13. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
Ma CX; Gao WC; Tian L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TP73-AS1 in human cancers.
Chu F; Xue L; Miao H
Clin Chim Acta; 2020 Jan; 500():104-108. PubMed ID: 31678571
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
20. The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells.
Varon M; Levy T; Mazor G; Ben David H; Marciano R; Krelin Y; Prasad M; Elkabets M; Pauck D; Ahmadov U; Picard D; Qin N; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Int J Cancer; 2019 Dec; 145(12):3402-3413. PubMed ID: 31081944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]